SHL Telemedicine Ltd. (SHLTN.SW)

CHF 2.9

(19.83%)

EBITDA Summary of SHL Telemedicine Ltd.

  • SHL Telemedicine Ltd.'s latest annual EBITDA in 2023 was 3.02 Million USD , down -66.85% from previous year.
  • SHL Telemedicine Ltd.'s latest quarterly EBITDA in 2023 FY was N/A , down -66.85% from previous quarter.
  • SHL Telemedicine Ltd. reported an annual EBITDA of 9.47 Million USD in 2022, up 129.16% from previous year.
  • SHL Telemedicine Ltd. reported an annual EBITDA of 4.35 Million USD in 2021, down -238.17% from previous year.
  • SHL Telemedicine Ltd. reported a quarterly EBITDA of -469 Thousand USD for 2023 Q1, up 66.27% from previous quarter.
  • SHL Telemedicine Ltd. reported a quarterly EBITDA of -469 Thousand USD for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of SHL Telemedicine Ltd. (2023 - 2002)

Historical Annual EBITDA of SHL Telemedicine Ltd. (2023 - 2002)

Year EBITDA EBITDA Growth
2023 3.02 Million USD -66.85%
2022 9.47 Million USD 129.16%
2021 4.35 Million USD -238.17%
2020 5.41 Million USD -42.59%
2019 8.98 Million USD -43.68%
2018 15.77 Million USD 84.85%
2017 8.65 Million USD 79.43%
2016 1.14 Million USD 185.64%
2015 -8.82 Million USD -170.77%
2014 8.85 Million USD 1835.53%
2013 7.87 Million USD 25.16%
2012 -743 Thousand USD -104.63%
2011 10.7 Million USD 6.71%
2010 15.17 Million USD -1.94%
2009 12.94 Million USD 13.81%
2008 11.37 Million USD -75.06%
2007 38.13 Million USD 370.23%
2006 9.7 Million USD 1968.66%
2005 469 Thousand USD 127.46%
2004 -1.7 Million USD -155.64%
2003 3.07 Million USD -73.66%
2002 11.65 Million USD 0.0%

Peer EBITDA Comparison of SHL Telemedicine Ltd.

Name EBITDA EBITDA Difference
Ascom Holding AG 31.3 Million CHF 90.339%